These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 24069355)

  • 21. Severe combined immunodeficiency (SCID) presenting in childhood, with agammaglobulinemia, associated with novel compound heterozygous mutations in DCLRE1C.
    Sundin M; Marits P; Ramme K; Kolios AGA; Nilsson J
    Clin Immunol; 2019 Mar; 200():16-18. PubMed ID: 30630113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lymphopoiesis in transgenic mice over-expressing Artemis.
    Rivera-Munoz P; Abramowski V; Jacquot S; André P; Charrier S; Lipson-Ruffert K; Fischer A; Galy A; Cavazzana M; de Villartay JP
    Gene Ther; 2016 Feb; 23(2):176-86. PubMed ID: 26361272
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel Artemis gene mutations of radiosensitive severe combined immunodeficiency in Japanese families.
    Kobayashi N; Agematsu K; Sugita K; Sako M; Nonoyama S; Yachie A; Kumaki S; Tsuchiya S; Ochs HD; Sugita K; Fukushima Y; Komiyama A
    Hum Genet; 2003 Apr; 112(4):348-52. PubMed ID: 12592555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA-PKcs deficiency in human: long predicted, finally found.
    van der Burg M; van Dongen JJ; van Gent DC
    Curr Opin Allergy Clin Immunol; 2009 Dec; 9(6):503-9. PubMed ID: 19823081
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD3ε
    Boettcher AN; Cino-Ozuna AG; Solanki Y; Wiarda JE; Putz E; Owens JL; Crane SA; Ahrens AP; Loving CL; Cunnick JE; Rowland RRR; Charley SE; Dekkers JCM; Tuggle CK
    Front Immunol; 2020; 11():510. PubMed ID: 32296428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of the human artemis promoter by heterologous gene expression in vitro and in vivo.
    Multhaup MM; Gurram S; Podetz-Pedersen KM; Karlen AD; Swanson DL; Somia NV; Hackett PB; Cowan MJ; McIvor RS
    DNA Cell Biol; 2011 Oct; 30(10):751-61. PubMed ID: 21663454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Defective Artemis nuclease is characterized by coding joints with microhomology in long palindromic-nucleotide stretches.
    van der Burg M; Verkaik NS; den Dekker AT; Barendregt BH; Pico-Knijnenburg I; Tezcan I; vanDongen JJ; van Gent DC
    Eur J Immunol; 2007 Dec; 37(12):3522-8. PubMed ID: 18034425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Partial T and B lymphocyte immunodeficiency and predisposition to lymphoma in patients with hypomorphic mutations in Artemis.
    Moshous D; Pannetier C; Chasseval Rd Rd; Deist Fl Fl; Cavazzana-Calvo M; Romana S; Macintyre E; Canioni D; Brousse N; Fischer A; Casanova JL; Villartay JP
    J Clin Invest; 2003 Feb; 111(3):381-7. PubMed ID: 12569164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural and mechanistic insights into the Artemis endonuclease and strategies for its inhibition.
    Yosaatmadja Y; Baddock HT; Newman JA; Bielinski M; Gavard AE; Mukhopadhyay SMM; Dannerfjord AA; Schofield CJ; McHugh PJ; Gileadi O
    Nucleic Acids Res; 2021 Sep; 49(16):9310-9326. PubMed ID: 34387696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A founder mutation in Artemis, an SNM1-like protein, causes SCID in Athabascan-speaking Native Americans.
    Li L; Moshous D; Zhou Y; Wang J; Xie G; Salido E; Hu D; de Villartay JP; Cowan MJ
    J Immunol; 2002 Jun; 168(12):6323-9. PubMed ID: 12055248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A hypomorphic Artemis human disease allele causes aberrant chromosomal rearrangements and tumorigenesis.
    Jacobs C; Huang Y; Masud T; Lu W; Westfield G; Giblin W; Sekiguchi JM
    Hum Mol Genet; 2011 Feb; 20(4):806-19. PubMed ID: 21147755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. T cell and B Cell immunity can be reconstituted with mismatched hematopoietic stem cell transplantation without alkylator therapy in artemis-deficient mice using anti-natural killer cell antibody and photochemically treated sensitized donor T cells.
    Xiao TZ; Singh K; Dunn E; Ramachandran R; Cowan MJ
    Biol Blood Marrow Transplant; 2012 Feb; 18(2):200-9. PubMed ID: 22015994
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Artemis, a novel guardian of the genome.
    Dudásová Z; Chovanec M
    Neoplasma; 2003; 50(5):311-8. PubMed ID: 14628082
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular analysis of T-B-NK+ severe combined immunodeficiency and Omenn syndrome cases in Saudi Arabia.
    Alsmadi O; Al-Ghonaium A; Al-Muhsen S; Arnaout R; Al-Dhekri H; Al-Saud B; Al-Kayal F; Al-Saud H; Al-Mousa H
    BMC Med Genet; 2009 Nov; 10():116. PubMed ID: 19912631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of transgene regulation in ex vivo lentiviral correction of artemis deficiency.
    Multhaup MM; Podetz-Pedersen KM; Karlen AD; Olson ER; Gunther R; Somia NV; Blazar BR; Cowan MJ; McIvor RS
    Hum Gene Ther; 2015 Apr; 26(4):232-43. PubMed ID: 25738323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A non-leaky Artemis-deficient mouse that accurately models the human severe combined immune deficiency phenotype, including resistance to hematopoietic stem cell transplantation.
    Xiao Z; Dunn E; Singh K; Khan IS; Yannone SM; Cowan MJ
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):1-11. PubMed ID: 19135937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutations in CHD7 in patients with CHARGE syndrome cause T-B + natural killer cell + severe combined immune deficiency and may cause Omenn-like syndrome.
    Gennery AR; Slatter MA; Rice J; Hoefsloot LH; Barge D; McLean-Tooke A; Montgomery T; Goodship JA; Burt AD; Flood TJ; Abinun M; Cant AJ; Johnson D
    Clin Exp Immunol; 2008 Jul; 153(1):75-80. PubMed ID: 18505430
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    Bin Y; Wei S; Chen R; Zhang H; Ren J; Liu P; Xin Z; Zhang T; Yang H; Wang K; Feng Z; Sun X; Chen Z; Zhang H
    Biomolecules; 2024 Feb; 14(2):. PubMed ID: 38397417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. More than just SCID--the phenotypic range of combined immunodeficiencies associated with mutations in the recombinase activating genes (RAG) 1 and 2.
    Niehues T; Perez-Becker R; Schuetz C
    Clin Immunol; 2010 May; 135(2):183-92. PubMed ID: 20172764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lentiviral Gene Therapy for Artemis-Deficient SCID.
    Cowan MJ; Yu J; Facchino J; Fraser-Browne C; Sanford U; Kawahara M; Dara J; Long-Boyle J; Oh J; Chan W; Chag S; Broderick L; Chellapandian D; Decaluwe H; Golski C; Hu D; Kuo CY; Miller HK; Petrovic A; Currier R; Hilton JF; Punwani D; Dvorak CC; Malech HL; McIvor RS; Puck JM
    N Engl J Med; 2022 Dec; 387(25):2344-2355. PubMed ID: 36546626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.